BRPI0917390A2 - dispositivo oftálmico tendo capacidade de liberação de agente terapêutico e método de formação do mesmo - Google Patents

dispositivo oftálmico tendo capacidade de liberação de agente terapêutico e método de formação do mesmo

Info

Publication number
BRPI0917390A2
BRPI0917390A2 BRPI0917390A BRPI0917390A BRPI0917390A2 BR PI0917390 A2 BRPI0917390 A2 BR PI0917390A2 BR PI0917390 A BRPI0917390 A BR PI0917390A BR PI0917390 A BRPI0917390 A BR PI0917390A BR PI0917390 A2 BRPI0917390 A2 BR PI0917390A2
Authority
BR
Brazil
Prior art keywords
formation
therapeutic agent
ophthalmic device
agent release
release capacity
Prior art date
Application number
BRPI0917390A
Other languages
English (en)
Inventor
Brett E Thomes
Chi-Chun Tsai
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Publication of BRPI0917390A2 publication Critical patent/BRPI0917390A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts or implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Prostheses (AREA)
BRPI0917390A 2008-07-21 2009-07-20 dispositivo oftálmico tendo capacidade de liberação de agente terapêutico e método de formação do mesmo BRPI0917390A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8235208P 2008-07-21 2008-07-21
PCT/US2009/051103 WO2010011585A2 (en) 2008-07-21 2009-07-20 Ophthalmic device having therapeutic agent delivery capability and method of forming same

Publications (1)

Publication Number Publication Date
BRPI0917390A2 true BRPI0917390A2 (pt) 2015-11-17

Family

ID=41445879

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0917390A BRPI0917390A2 (pt) 2008-07-21 2009-07-20 dispositivo oftálmico tendo capacidade de liberação de agente terapêutico e método de formação do mesmo

Country Status (16)

Country Link
US (3) US9233069B2 (pt)
EP (1) EP2303331B1 (pt)
JP (3) JP5954888B2 (pt)
KR (1) KR101663111B1 (pt)
CN (1) CN102231989B (pt)
AR (1) AR073460A1 (pt)
AU (2) AU2009274209B2 (pt)
BR (1) BRPI0917390A2 (pt)
CA (1) CA2730264C (pt)
ES (1) ES2909726T3 (pt)
IL (1) IL210385A (pt)
MX (1) MX340636B (pt)
NZ (1) NZ590472A (pt)
RU (1) RU2519704C2 (pt)
TW (1) TWI531362B (pt)
WO (1) WO2010011585A2 (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008157372A2 (en) 2007-06-14 2008-12-24 Massachusetts Institute Of Technology Self assembled films for protein and drug delivery applications
WO2010021973A2 (en) * 2008-08-17 2010-02-25 Massachusetts Institute Of Technology Controlled delivery of bioactive agents from decomposable films
WO2011140136A2 (en) * 2010-05-03 2011-11-10 Massachusetts Institute Of Technology Drug delivery coating and devices
US8235053B2 (en) 2010-09-08 2012-08-07 Alcon Research, Ltd. Implantable punctal plug
US8864703B2 (en) 2010-10-05 2014-10-21 Alcon Research, Ltd. Drug introduction and placement system
EP2841056A4 (en) 2012-04-23 2015-09-16 Massachusetts Inst Technology STABLE LAYER COATED PARTICLES
WO2014038004A1 (ja) * 2012-09-05 2014-03-13 株式会社メニコン 薬物徐放性眼用レンズ及びその製造方法
WO2014134029A1 (en) 2013-02-26 2014-09-04 Massachusetts Institute Of Technology Nucleic acid particles, methods and use thereof
US9463244B2 (en) 2013-03-15 2016-10-11 Massachusetts Institute Of Technology Compositions and methods for nucleic acid delivery
WO2014196357A1 (ja) * 2013-06-03 2014-12-11 王子ホールディングス株式会社 微細繊維含有シートの製造方法
US9949874B2 (en) * 2014-06-06 2018-04-24 Janssen Biotech, Inc. Therapeutic agent delivery device with convergent lumen
FR3028410A1 (fr) 2014-11-18 2016-05-20 Pierre Coulon Implant capsulaire multifonctionnel
TWI606850B (zh) * 2015-12-22 2017-12-01 美樺興業股份有限公司 人工水晶體以及其製作方法
RU2612121C1 (ru) * 2016-01-27 2017-03-02 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт глазных болезней" Лечебная силикон-гидрогелевая мягкая контактная линза
EP3210572A1 (en) 2016-02-29 2017-08-30 Elodie Jane Siney Intraocular lens comprising drug-containing microspheres
WO2019089567A1 (en) 2017-10-30 2019-05-09 Massachusetts Institute Of Technology Layer-by-layer nanoparticles for cytokine therapy in cancer treatment
CN108578768B (zh) * 2018-03-23 2020-05-01 四川大学 一种高强度可注射的人工晶状体材料及其制备方法和应用
AU2019280534B2 (en) * 2018-06-05 2022-04-07 Corneat Vision Ltd. A synthetic ophthalmic graft patch
US11806278B2 (en) * 2018-08-30 2023-11-07 Qura, Inc. Implantable intraocular drug delivery devices
WO2021002984A1 (en) 2019-05-30 2021-01-07 Massachusetts Institute Of Technology Peptide nucleic acid functionalized hydrogel microneedles for sampling and detection of interstitial fluid nucleic acids
AU2020302924A1 (en) * 2019-06-27 2022-02-17 Layerbio, Inc. Ocular device delivery methods and systems
CN115364280B (zh) * 2021-12-15 2023-08-18 郑州大学第一附属医院 一种药物缓释型人工晶状体及其制备方法

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4240163A (en) 1979-01-31 1980-12-23 Galin Miles A Medicament coated intraocular lens
US5098443A (en) 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US6197059B1 (en) 1990-04-27 2001-03-06 Medevec Licensing, B.V. Accomodating intraocular lens
US5290892A (en) * 1990-11-07 1994-03-01 Nestle S.A. Flexible intraocular lenses made from high refractive index polymers
US5470932A (en) 1993-10-18 1995-11-28 Alcon Laboratories, Inc. Polymerizable yellow dyes and their use in opthalmic lenses
JP3206004B2 (ja) * 1995-06-07 2001-09-04 アルコン ラボラトリーズ， インコーポレイテッド 改良された高屈折率の眼科用レンズ材料
US5554187A (en) 1995-08-18 1996-09-10 Rizzo, Iii; Joseph Medication dispensing intra-ocular lens system
CN1210554A (zh) 1996-02-09 1999-03-10 表面溶解实验室公司 水基亲水涂料组合物及由其制备的产品
ATE218085T1 (de) * 1996-11-01 2002-06-15 Alcon Lab Inc Polierverfahren für weiche acrylgegenstände
FR2757064B1 (fr) 1996-12-13 2000-02-04 Ioltechnologie Production Lentille intraoculaire contenant un medicament relargable
US5843186A (en) 1996-12-20 1998-12-01 Implemed, Inc. Intraocular lens with antimicrobial activity
US6353069B1 (en) 1998-04-15 2002-03-05 Alcon Manufacturing, Ltd. High refractive index ophthalmic device materials
US6106554A (en) 1999-02-25 2000-08-22 Bausch & Lomb Surgical, Inc. Intraocular lens implants for the prevention of secondary cataracts
AU2002210926B2 (en) 2000-10-24 2005-12-15 Shunichi Shiozawa Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis
GB2399753B (en) 2002-01-18 2006-04-19 Michael E Snyder Method of making a sustained release ophthalmological device
US7153573B2 (en) * 2002-08-08 2006-12-26 Kao Corporation Polymer composite particle comprising metal oxide and silicone and/or fluorine and method of producing the same
GB0219024D0 (en) 2002-08-15 2002-09-25 Pfizer Ltd Synergistic combinations
US7273896B2 (en) 2003-04-10 2007-09-25 Angiotech Pharmaceuticals (Us), Inc. Compositions and methods of using a transient colorant
RU2251394C2 (ru) * 2003-06-23 2005-05-10 Войсковая Часть 41598 Композиция и способ изготовления лечебной мягкой контактной линзы
TWI358290B (en) * 2004-12-02 2012-02-21 Alcon Inc Topical nepafenac formulations
CA2606284C (en) * 2005-05-25 2014-04-08 Chemisches Institut Schaefer Ag Biocompatible polymers and co-polymers, and uses thereof
US20070218104A1 (en) 2006-03-15 2007-09-20 Bausch & Lomb Incorporation Rate controlled release of a pharmaceutical agent in a biodegradable device
AR063561A1 (es) 2006-11-06 2009-02-04 Novartis Ag Dispositivos oculares y metodos para fabricar y utilizar los mismos

Also Published As

Publication number Publication date
WO2010011585A3 (en) 2011-04-07
AU2015213358A1 (en) 2015-09-03
KR101663111B1 (ko) 2016-10-06
JP2011528714A (ja) 2011-11-24
TWI531362B (zh) 2016-05-01
US9750685B2 (en) 2017-09-05
EP2303331A2 (en) 2011-04-06
KR20110033288A (ko) 2011-03-30
TW201004611A (en) 2010-02-01
US20170319474A1 (en) 2017-11-09
US20160081921A1 (en) 2016-03-24
US9233069B2 (en) 2016-01-12
MX340636B (es) 2016-07-19
US20100016439A1 (en) 2010-01-21
AU2009274209B2 (en) 2015-05-14
RU2011106329A (ru) 2012-08-27
CN102231989A (zh) 2011-11-02
CA2730264A1 (en) 2010-01-28
JP5954888B2 (ja) 2016-07-20
JP2014196357A (ja) 2014-10-16
EP2303331B1 (en) 2022-01-26
ES2909726T3 (es) 2022-05-10
IL210385A0 (en) 2011-03-31
CA2730264C (en) 2016-08-16
RU2519704C2 (ru) 2014-06-20
IL210385A (en) 2015-11-30
CN102231989B (zh) 2013-08-21
MX2011000774A (es) 2011-02-23
WO2010011585A2 (en) 2010-01-28
NZ590472A (en) 2012-11-30
AU2009274209A1 (en) 2010-01-28
AR073460A1 (es) 2010-11-10
US9962334B2 (en) 2018-05-08
JP2016130267A (ja) 2016-07-21

Similar Documents

Publication Publication Date Title
BRPI0917390A2 (pt) dispositivo oftálmico tendo capacidade de liberação de agente terapêutico e método de formação do mesmo
BRPI0916049A2 (pt) "dispositivo para tratamento da cavidade dental e método para tratamento da cavidade dental"
EP2131912A4 (en) OCCLUSION DEVICE AND METHOD OF USE
BRPI1008834A2 (pt) dispositivo compactos de monitoramento fisiológico no corpo e métodos dos mesmos
EP2268351A4 (en) CLOSING DEVICE AND METHOD FOR THEIR USE
BRPI0920030A2 (pt) agente de oclusão do tecido
BRPI0920314A2 (pt) dispositivo médico com liberação controlada de agente antibacteriano
EP2083774A4 (en) THERAPEUTIC INTRAVAGINAL DEVICES AND METHOD
BRPI0807525A2 (pt) Dispositivo endo-cirúrgico e método
EP2091588A4 (en) CARDIAL DEVICE AND USE METHOD THEREFOR
BRPI0916269A2 (pt) dispositivo de modificação de tecido e seu método de uso
BRPI0922440A2 (pt) dispositivo protético e método de fabricação do mesmo .
BRPI1016147A2 (pt) sistema intrauterino para uso no tratamento de uma condição médica, e, método para a fabricação de um sistema intrauterino
PL2294582T3 (pl) Urządzenie i sposób wytwarzania izotopów medycznych
BRPI0810081A2 (pt) Agente terapêutico e agente diagnóstico para doenças cerebrais de disfunção mitocondrial
HRP20190031T1 (hr) Sintetski triterpenoidi i postupci njihove upotrebe u liječenju bolesti
BRPI0820882A2 (pt) Dispositivos e métodos de estimulação de dermátomo
ZA200901842B (en) Ocular devices and methods of making and using thereof
PL2037902T3 (pl) Zastosowanie kanabidiolu w użyciu w leczeniu bólu neuropatycznego
BR112012004148A2 (pt) "dispositivo médico para colocação em um lúmen e método de fabricação do mesmo"
BRPI0918573A2 (pt) dispositivo de proteção embólica temporária e procedimento médico para sua distribuição
BRPI0910760A2 (pt) método para remineralizar tecido, agente remineralizador, e, kit
BRPI1006733A2 (pt) kit para formação de imagem médica marcada e/ou produtos terapêuticos, agente de pré-marcação, sonda de formação de imagem, sonda terapêutica e método
BRPI0922817A2 (pt) corpo médico absorvente, em particular para remoção de fluidos de feridas de cavidades do corpo humano e/ou de um animal e métodos para sua produção
BRPI0910997A2 (pt) dispositivo e método de fabricação de um corpo absorvente

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06G Technical and formal requirements: other requirements [chapter 6.7 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B25A Requested transfer of rights approved

Owner name: NOVARTIS AG (CH)

B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL